Enzychem
183490.KQEnzychem Lifesciences Corporation Price (183490.KQ)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
84,929,236
(7.751)%Income Statement Summary
| Revenue | |
| Cost of Revenue | |
| Gross Profit | |
| Operating Expenses | |
| Operating Income | |
| Other Expenses | |
| Net Income |
Income Statement
Enzychem Lifesciences CorporationCurrency: KRW
| YEAR | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Revenue |
21,835,379,807.00
+0% |
26,133,210,513.00
+20% |
31,034,039,114.00
+19% |
31,468,723,444.00
+1% |
25,818,432,585.00
-18% |
22,975,498,508.00
-11% |
26,637,631,236.00
+16% |
76,038,893,905.00
+185% |
|||||||||||
| Cost of Revenue | |||||||||||||||||||
| Cost of Revenue | 18,854,377,572.00 | 22,582,871,433.00 | 27,183,205,778.00 | 29,345,471,249.00 | 24,494,688,336.00 | 23,352,287,973.00 | 25,018,980,141.00 | 71,690,743,600.00 | |||||||||||
| Gross Profit | |||||||||||||||||||
| Gross Profit |
2,981,002,235.00
+0% |
3,550,339,080.00
+19% |
3,850,833,336.00
+8% |
2,123,252,195.00
-45% |
1,323,744,249.00
-38% |
-376,789,465.00
-128% |
1,618,651,095.00
-530% |
4,348,150,305.00
+169% |
|||||||||||
| Gross Profit Ratio | (0.14%) | (0.14%) | (0.12%) | (0.07%) | (0.05%) | (-0.02%) | (0.06%) | (0.06%) | |||||||||||
| Operating Expenses | |||||||||||||||||||
| Research and Development | 5,149,932,677.00 | 4,199,399,311.00 | 10,160,779,670.00 | 11,443,110,962.00 | 12,865,497,234.00 | 9,501,095,280.00 | 6,698,591,847.00 | 5,433,778,038.00 | |||||||||||
| General and Administrative | 0.00 | 45,732,830.00 | 4,454,989,751.00 | 4,881,318,500.00 | 1,414,538,270.00 | 2,192,801,280.00 | 1,758,616,830.00 | 2,090,419,540.00 | |||||||||||
| Selling, General & Admin... | 4,057,670,533.00 | 4,731,369,571.00 | 8,653,964,787.00 | 7,082,321,990.00 | 7,565,689,979.00 | 10,875,631,571.00 | 9,722,585,030.00 | 12,593,064,327.00 | |||||||||||
| Selling & Marketing Exp... | 0.00 | 1,903,608,720.00 | 4,198,975,029.00 | 2,201,003,500.00 | 2,035,107,770.00 | 2,887,985,000.00 | 2,761,323,580.00 | 4,107,471,110.00 | |||||||||||
| Depreciation and Amortiz... | 1,340,791,378.00 | 1,578,603,895.00 | 1,533,053,633.00 | 1,946,650,292.00 | 2,035,898,758.00 | 2,111,007,183.00 | 2,389,005,404.00 | 3,512,018,720.00 | |||||||||||
| Other Expenses | 0.00 | -15,708,210.00 | -6,419,630.00 | -374,620.00 | 1,277,903,600.00 | 312,945,970.00 | 14,298,570.00 | 0.00 | |||||||||||
| Total Operating Expenses | 9,207,603,210.00 | 8,946,477,093.00 | 18,821,164,087.00 | 18,525,807,572.00 | 19,153,283,613.00 | 20,376,726,851.00 | 16,421,176,877.00 | 18,704,294,990.00 | |||||||||||
| Cost and Exponses | 28,061,980,782.00 | 31,529,348,522.00 | 46,004,369,861.00 | 47,871,278,824.00 | 43,647,971,952.00 | 43,729,014,824.00 | 41,440,157,018.00 | 90,395,038,590.00 | |||||||||||
| Operating Income | |||||||||||||||||||
| Operating Income |
-6,226,600,970.00
+0% |
-5,396,138,010.00
-13% |
-14,970,330,750.00
+177% |
-16,402,555,380.00
+10% |
-17,829,539,360.00
+9% |
-20,753,516,320.00
+16% |
-14,802,525,780.00
-29% |
-14,356,144,690.00
-3% |
|||||||||||
| Operating Income Ratio | (-0.29%) | (-0.21%) | (-0.48%) | (-0.52%) | (-0.69%) | (-0.90%) | (-0.56%) | (-0.19%) | |||||||||||
| Other Income and Exp... | |||||||||||||||||||
| Interest Income | 109,131,536.00 | 127,727,660.00 | 260,258,310.00 | 691,243,552.00 | 552,021,490.00 | 963,708,920.00 | 3,976,234,530.00 | 5,489,404,420.00 | |||||||||||
| Interest Expenses | 221,873,516.00 | 184,886,240.00 | 110,492,200.00 | 158,266,566.00 | 1,429,642,000.00 | 9,508,410,670.00 | 10,030,413,820.00 | 620,094,350.00 | |||||||||||
| Total Other Income/Exp... | -68,632,290.00 | -236,016,056.00 | 48,248,510.00 | -272,975,219.00 | -124,555,070.00 | -8,750,902,040.00 | -10,778,855,850.00 | 4,477,192,780.00 | |||||||||||
| EBITDA | |||||||||||||||||||
| EBITDA | -4,787,913,381.00 | -3,868,663,939.00 | -12,637,421,778.00 | -14,455,530,470.00 | -15,715,794,369.00 | -17,874,169,555.00 | -13,156,023,050.00 | -5,773,704,342.00 | |||||||||||
| EBITDA ratio | (-0.22%) | (-0.15%) | (-0.43%) | (-0.46%) | (-0.61%) | (-0.81%) | (-0.47%) | (-0.08%) | |||||||||||
| Income Before Tax | |||||||||||||||||||
| Income Before Tax | -6,295,233,270.00 | -5,632,154,066.00 | -14,280,967,611.00 | -17,380,230,349.00 | -19,181,335,127.00 | -29,493,587,411.00 | -25,575,442,283.00 | -9,878,951,910.00 | |||||||||||
| Income Before Tax Ratio | (-0.29%) | (-0.22%) | (-0.46%) | (-0.55%) | (-0.74%) | (-1.28%) | (-0.96%) | (-0.13%) | |||||||||||
| Income Tax Expense | |||||||||||||||||||
| Income Tax Expense | 36,394,062.00 | 34,273,537.00 | 139,263,291.00 | 203,545,950.00 | -1,725,070,031.00 | -1,639,585,514.00 | -488,271,922.00 | -476,299,606.00 | |||||||||||
| Net Income | |||||||||||||||||||
| Net Income | -6,331,627,332.00
+0% |
-5,666,427,603.00
-11% |
-14,420,230,902.00
+154% |
-16,879,076,539.00
+17% |
-17,506,927,997.00
+4% |
-27,864,832,842.00
+59% |
-25,093,109,710.00
-10% |
-9,326,411,514.00
-63% |
|||||||||||
| Net Income Ratio | (-0.29%) | (-0.22%) | (-0.46%) | (-0.54%) | (-0.68%) | (-1.21%) | (-0.94%) | (-0.12%) | |||||||||||
| Earning Per Share | |||||||||||||||||||
| Basic EPS | -127.66 | -109.39 | -251.00 | -284.31 | -284.83 | -558.47 | -318.36 | -109.81 | |||||||||||
| Diluted EPS | -127.66 | -109.39 | -251.00 | -284.31 | -284.83 | -558.47 | -318.36 | -109.81 | |||||||||||
| Share Outstanding | |||||||||||||||||||
| Basic Share Outstanding | 49,598,143.00 | 51,801,998.00 | 57,450,220.00 | 59,369,525.00 | 61,464,846.00 | 49,894,598.00 | 78,819,911.00 | 84,929,236.00 | |||||||||||
| Diluted Share Outstanding | 49,598,143.00 | 51,801,998.00 | 57,450,220.00 | 59,369,525.00 | 61,464,846.00 | 49,894,598.00 | 78,819,911.00 | 84,929,236.00 | |||||||||||